KORU Medical Systems, Inc. Common Stock (DE) (KRMD)
KORU Medical Systems, Inc. (KRMD) specializes in developing and commercializing advanced infusion systems for the delivery of medication and fluids. The company focuses on designing innovative devices aimed at improving patient care and healthcare provider efficiency, particularly in the areas of fluid management and medical infusion.
Company News
Cirtec Medical has appointed Shar Matin as its new CEO, effective September 2, 2025. Matin brings over 25 years of global leadership experience in medical technology, previously serving as CEO of Cordis and holding executive roles at multiple medical technology companies.
KORU Medical Systems Inc. (KRMD) delivered earnings and revenue surprises of 50% and 9.45%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
B. Riley has initiated coverage of KORU Medical Systems Inc (NASDAQ: KRMD) with a Buy rating and a price target of $4.50. The analyst Neil Chatterji notes that KORU Medical's innovative Freedom Infusion System represents a significant advancement in medical treatment by delivering drugs subcutaneously (under the skin). The system primaril...